nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—GJA1—periosteum—cleft lip	0.08	0.192	CbGeAlD
Carvedilol—VCAM1—tongue—cleft lip	0.0363	0.087	CbGeAlD
Carvedilol—VCAM1—mouth—cleft lip	0.0244	0.0585	CbGeAlD
Carvedilol—HIF1A—mouth—cleft lip	0.0235	0.0563	CbGeAlD
Carvedilol—GJA1—mouth—cleft lip	0.0228	0.0546	CbGeAlD
Carvedilol—NDUFC2—mouth—cleft lip	0.0198	0.0475	CbGeAlD
Carvedilol—HIF1A—embryo—cleft lip	0.0167	0.0401	CbGeAlD
Carvedilol—GJA1—embryo—cleft lip	0.0162	0.0389	CbGeAlD
Carvedilol—NPPB—head—cleft lip	0.0142	0.034	CbGeAlD
Carvedilol—HIF1A—telencephalon—cleft lip	0.0136	0.0326	CbGeAlD
Carvedilol—GJA1—telencephalon—cleft lip	0.0132	0.0317	CbGeAlD
Carvedilol—NDUFC2—telencephalon—cleft lip	0.0115	0.0276	CbGeAlD
Carvedilol—VEGFA—telencephalon—cleft lip	0.0104	0.025	CbGeAlD
Carvedilol—SELE—head—cleft lip	0.00957	0.023	CbGeAlD
Carvedilol—VCAM1—head—cleft lip	0.0088	0.0211	CbGeAlD
Carvedilol—HIF1A—head—cleft lip	0.00847	0.0203	CbGeAlD
Carvedilol—GJA1—head—cleft lip	0.00822	0.0197	CbGeAlD
Carvedilol—NDUFC2—head—cleft lip	0.00715	0.0172	CbGeAlD
Carvedilol—ADRA1D—telencephalon—cleft lip	0.00681	0.0163	CbGeAlD
Carvedilol—CYP1A1—mouth—cleft lip	0.0055	0.0132	CbGeAlD
Carvedilol—ADRB1—telencephalon—cleft lip	0.00495	0.0119	CbGeAlD
Carvedilol—ADRA1B—head—cleft lip	0.00433	0.0104	CbGeAlD
Carvedilol—ADRA1D—head—cleft lip	0.00424	0.0102	CbGeAlD
Carvedilol—ADRA1A—telencephalon—cleft lip	0.00391	0.00938	CbGeAlD
Carvedilol—KCNH2—telencephalon—cleft lip	0.00378	0.00906	CbGeAlD
Carvedilol—ADRA2C—telencephalon—cleft lip	0.00373	0.00894	CbGeAlD
Carvedilol—ADRB1—head—cleft lip	0.00308	0.00739	CbGeAlD
Carvedilol—ADRA2A—telencephalon—cleft lip	0.00297	0.00713	CbGeAlD
Carvedilol—CYP2E1—telencephalon—cleft lip	0.00291	0.00698	CbGeAlD
Carvedilol—PTGS1—telencephalon—cleft lip	0.0028	0.00672	CbGeAlD
Carvedilol—ADRA1A—head—cleft lip	0.00243	0.00584	CbGeAlD
Carvedilol—KCNH2—head—cleft lip	0.00235	0.00564	CbGeAlD
Carvedilol—ADRA2C—head—cleft lip	0.00232	0.00557	CbGeAlD
Carvedilol—CYP2D6—telencephalon—cleft lip	0.0023	0.00553	CbGeAlD
Carvedilol—ABCB1—embryo—cleft lip	0.00204	0.00489	CbGeAlD
Carvedilol—CYP1A1—head—cleft lip	0.00199	0.00477	CbGeAlD
Carvedilol—ADRA2A—head—cleft lip	0.00185	0.00444	CbGeAlD
Carvedilol—CYP2E1—head—cleft lip	0.00181	0.00435	CbGeAlD
Carvedilol—PTGS1—head—cleft lip	0.00174	0.00419	CbGeAlD
Carvedilol—ABCB1—telencephalon—cleft lip	0.00166	0.00397	CbGeAlD
Carvedilol—CYP2D6—head—cleft lip	0.00143	0.00344	CbGeAlD
Carvedilol—ABCB1—head—cleft lip	0.00103	0.00248	CbGeAlD
Carvedilol—ADRA2A—Signaling by GPCR—WNT3—cleft lip	0.000333	0.000571	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—WNT9B—cleft lip	0.00033	0.000565	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—WNT9B—cleft lip	0.000327	0.00056	CbGpPWpGaD
Carvedilol—HIF1A—Disease—FGF2—cleft lip	0.000325	0.000557	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—WNT9B—cleft lip	0.000322	0.000553	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—ABCA4—cleft lip	0.000322	0.000553	CbGpPWpGaD
Carvedilol—HIF1A—Disease—NOS3—cleft lip	0.000321	0.00055	CbGpPWpGaD
Carvedilol—CYP1A2—Aryl Hydrocarbon Receptor—MYC—cleft lip	0.000318	0.000546	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—cleft lip	0.000316	0.000542	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—NOG—cleft lip	0.000316	0.000542	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—NOG—cleft lip	0.000313	0.000537	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—FGFR1—cleft lip	0.000312	0.000534	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—NOG—cleft lip	0.000309	0.00053	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—WNT9B—cleft lip	0.000305	0.000523	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—WNT9B—cleft lip	0.0003	0.000515	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—SLC19A1—cleft lip	0.000297	0.00051	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—SLC19A1—cleft lip	0.000297	0.000509	CbGpPWpGaD
Carvedilol—VEGFA—Developmental Biology—FGF2—cleft lip	0.000295	0.000506	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—FGFR3—cleft lip	0.000295	0.000505	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—ABCA4—cleft lip	0.000294	0.000504	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—NOG—cleft lip	0.000292	0.000501	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—SPRY2—cleft lip	0.000292	0.0005	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—FGF7—cleft lip	0.000292	0.0005	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—ABCA4—cleft lip	0.000291	0.000499	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—FGF7—cleft lip	0.000291	0.000499	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—SPRY2—cleft lip	0.000291	0.000499	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—NOG—cleft lip	0.000288	0.000494	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—WNT3—cleft lip	0.000287	0.000493	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—ABCA4—cleft lip	0.000287	0.000493	CbGpPWpGaD
Carvedilol—VEGFA—Hemostasis—NOS3—cleft lip	0.000286	0.00049	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—ABCA4—cleft lip	0.000272	0.000466	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—FGF8—cleft lip	0.000269	0.000462	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—FGF8—cleft lip	0.000269	0.000461	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—ABCA4—cleft lip	0.000268	0.000459	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	0.000267	0.000459	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—WNT9B—cleft lip	0.000267	0.000457	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—PTCH1—cleft lip	0.000267	0.000457	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—WNT3—cleft lip	0.000262	0.000449	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—WNT3—cleft lip	0.000259	0.000445	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—WNT3—cleft lip	0.000256	0.000439	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—NOG—cleft lip	0.000256	0.000438	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—WNT9B—cleft lip	0.000248	0.000425	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—TCN2—cleft lip	0.000246	0.000423	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—TCN2—cleft lip	0.000246	0.000422	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—PTCH1—cleft lip	0.000243	0.000416	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—WNT3—cleft lip	0.000242	0.000416	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—PTCH1—cleft lip	0.000242	0.000414	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—SLC19A1—cleft lip	0.000242	0.000414	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—PTCH1—cleft lip	0.000241	0.000414	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—PTCH1—cleft lip	0.000241	0.000413	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—WNT3—cleft lip	0.000239	0.000409	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—ABCA4—cleft lip	0.000238	0.000408	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—PTCH1—cleft lip	0.000238	0.000407	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—NOG—cleft lip	0.000238	0.000407	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—FGF2—cleft lip	0.000228	0.00039	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—PTCH1—cleft lip	0.000225	0.000385	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—NOS3—cleft lip	0.000225	0.000385	CbGpPWpGaD
Carvedilol—XDH—Metabolism—TYMS—cleft lip	0.000223	0.000383	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—SLC19A1—cleft lip	0.000222	0.00038	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—PTCH1—cleft lip	0.000221	0.000379	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—ABCA4—cleft lip	0.000221	0.000379	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—FGF3—cleft lip	0.000219	0.000376	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—FGF3—cleft lip	0.000219	0.000375	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—FGF9—cleft lip	0.000214	0.000366	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—FGF9—cleft lip	0.000213	0.000366	CbGpPWpGaD
Carvedilol—HIF1A—Disease—MYC—cleft lip	0.000213	0.000364	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—WNT3—cleft lip	0.000212	0.000363	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—SLC19A1—cleft lip	0.000209	0.000359	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—TCN2—cleft lip	0.0002	0.000343	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—WNT3—cleft lip	0.000197	0.000337	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—PTCH1—cleft lip	0.000196	0.000337	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.000195	0.000335	CbGpPWpGaD
Carvedilol—XDH—Metabolism—MTHFR—cleft lip	0.000195	0.000334	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—FGF7—cleft lip	0.00019	0.000326	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—SPRY2—cleft lip	0.00019	0.000326	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—TCN2—cleft lip	0.000184	0.000315	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—PTCH1—cleft lip	0.000183	0.000313	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—FGF10—cleft lip	0.00018	0.000309	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—FGF10—cleft lip	0.00018	0.000308	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—FGF8—cleft lip	0.000175	0.000301	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—TCN2—cleft lip	0.000173	0.000297	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—FGF7—cleft lip	0.000173	0.000297	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—SPRY2—cleft lip	0.000173	0.000297	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—FGF7—cleft lip	0.000172	0.000294	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—SPRY2—cleft lip	0.000172	0.000294	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—MTR—cleft lip	0.000171	0.000293	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—MTR—cleft lip	0.00017	0.000292	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—FGF7—cleft lip	0.000169	0.00029	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—SPRY2—cleft lip	0.000169	0.00029	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—NOS3—cleft lip	0.000168	0.000289	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—SLC19A1—cleft lip	0.000167	0.000286	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—FGF7—cleft lip	0.00016	0.000275	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—SPRY2—cleft lip	0.00016	0.000275	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—FGF8—cleft lip	0.00016	0.000274	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—FGF8—cleft lip	0.000158	0.000271	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—FGF7—cleft lip	0.000158	0.00027	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—SPRY2—cleft lip	0.000158	0.00027	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—PTCH1—cleft lip	0.000157	0.00027	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—SLC19A1—cleft lip	0.000157	0.00027	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—NOS3—cleft lip	0.000157	0.00027	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—FGF8—cleft lip	0.000156	0.000268	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—SLC19A1—cleft lip	0.000156	0.000268	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—MYC—cleft lip	0.000149	0.000255	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—FGF8—cleft lip	0.000148	0.000254	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—FGF8—cleft lip	0.000146	0.00025	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—FGFR2—cleft lip	0.000145	0.000248	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—FGFR2—cleft lip	0.000144	0.000247	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—PTCH1—cleft lip	0.000143	0.000246	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—FGF3—cleft lip	0.000143	0.000245	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—PTCH1—cleft lip	0.000142	0.000244	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—PTCH1—cleft lip	0.00014	0.000241	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—SPRY2—cleft lip	0.00014	0.00024	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—FGF7—cleft lip	0.00014	0.00024	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—FGF9—cleft lip	0.000139	0.000239	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—MTR—cleft lip	0.000139	0.000238	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—TCN2—cleft lip	0.000138	0.000237	CbGpPWpGaD
Carvedilol—XDH—Metabolism—NOS3—cleft lip	0.000136	0.000233	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—FGFR1—cleft lip	0.000135	0.000231	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—FGFR1—cleft lip	0.000135	0.000231	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—SLC19A1—cleft lip	0.000133	0.000229	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—PTCH1—cleft lip	0.000133	0.000228	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—PTCH1—cleft lip	0.000131	0.000224	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—TCN2—cleft lip	0.00013	0.000224	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—SPRY2—cleft lip	0.00013	0.000223	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—FGF7—cleft lip	0.00013	0.000223	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—FGF3—cleft lip	0.00013	0.000223	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—TCN2—cleft lip	0.000129	0.000222	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—FGF8—cleft lip	0.000129	0.000222	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—FGF3—cleft lip	0.000129	0.000221	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—NOS3—cleft lip	0.000128	0.000219	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.000128	0.000219	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—MTR—cleft lip	0.000127	0.000218	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—FGFR3—cleft lip	0.000127	0.000218	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—FGF3—cleft lip	0.000127	0.000218	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—FGFR3—cleft lip	0.000127	0.000218	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—FGF9—cleft lip	0.000127	0.000217	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—FGF9—cleft lip	0.000126	0.000215	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—FGF9—cleft lip	0.000124	0.000213	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—FGF3—cleft lip	0.00012	0.000206	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—FGF8—cleft lip	0.00012	0.000206	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—MTR—cleft lip	0.00012	0.000206	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—FGF3—cleft lip	0.000118	0.000203	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—FGF10—cleft lip	0.000117	0.000201	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—FGF9—cleft lip	0.000117	0.000201	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—PTCH1—cleft lip	0.000116	0.000199	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—FGF9—cleft lip	0.000116	0.000198	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—TCN2—cleft lip	0.00011	0.000189	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—PTCH1—cleft lip	0.000108	0.000185	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—FGF10—cleft lip	0.000107	0.000183	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—FGF10—cleft lip	0.000106	0.000182	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—FGF3—cleft lip	0.000105	0.00018	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—TYMS—cleft lip	0.000105	0.00018	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—FGF10—cleft lip	0.000105	0.000179	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—TYMS—cleft lip	0.000104	0.000179	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—SLC19A1—cleft lip	0.000103	0.000176	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—FGF9—cleft lip	0.000103	0.000176	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—FGF10—cleft lip	9.9e-05	0.00017	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—FGF2—cleft lip	9.85e-05	0.000169	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—FGF2—cleft lip	9.82e-05	0.000168	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—FGF3—cleft lip	9.78e-05	0.000168	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—FGF10—cleft lip	9.74e-05	0.000167	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—NOS3—cleft lip	9.71e-05	0.000166	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—NOS3—cleft lip	9.69e-05	0.000166	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—MTR—cleft lip	9.59e-05	0.000164	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—FGF9—cleft lip	9.53e-05	0.000163	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—FGFR2—cleft lip	9.42e-05	0.000162	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—MTHFR—cleft lip	9.15e-05	0.000157	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—MTHFR—cleft lip	9.13e-05	0.000157	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—MTR—cleft lip	9.04e-05	0.000155	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—MTR—cleft lip	8.96e-05	0.000154	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—FGFR1—cleft lip	8.78e-05	0.000151	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—FGF10—cleft lip	8.65e-05	0.000148	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—FGFR2—cleft lip	8.58e-05	0.000147	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—TCN2—cleft lip	8.53e-05	0.000146	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—FGFR2—cleft lip	8.51e-05	0.000146	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—TYMS—cleft lip	8.5e-05	0.000146	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—FGFR2—cleft lip	8.4e-05	0.000144	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—FGFR3—cleft lip	8.3e-05	0.000142	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—FGF10—cleft lip	8.04e-05	0.000138	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—FGFR1—cleft lip	8e-05	0.000137	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—FGFR2—cleft lip	7.94e-05	0.000136	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—FGFR1—cleft lip	7.93e-05	0.000136	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—FGFR1—cleft lip	7.83e-05	0.000134	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—FGFR2—cleft lip	7.82e-05	0.000134	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—TYMS—cleft lip	7.81e-05	0.000134	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—MTR—cleft lip	7.66e-05	0.000131	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—FGFR3—cleft lip	7.56e-05	0.00013	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—FGFR3—cleft lip	7.49e-05	0.000128	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—MTHFR—cleft lip	7.43e-05	0.000127	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—FGFR1—cleft lip	7.41e-05	0.000127	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—FGFR3—cleft lip	7.4e-05	0.000127	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—TYMS—cleft lip	7.36e-05	0.000126	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—FGFR1—cleft lip	7.29e-05	0.000125	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—FGFR3—cleft lip	7e-05	0.00012	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—FGFR2—cleft lip	6.95e-05	0.000119	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—FGFR3—cleft lip	6.89e-05	0.000118	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—MTHFR—cleft lip	6.82e-05	0.000117	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—FGFR1—cleft lip	6.47e-05	0.000111	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—FGFR2—cleft lip	6.45e-05	0.000111	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—MYC—cleft lip	6.44e-05	0.00011	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—MTHFR—cleft lip	6.43e-05	0.00011	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—MYC—cleft lip	6.42e-05	0.00011	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—FGF2—cleft lip	6.41e-05	0.00011	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—NOS3—cleft lip	6.38e-05	0.000109	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—NOS3—cleft lip	6.37e-05	0.000109	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—NOS3—cleft lip	6.32e-05	0.000108	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—FGFR3—cleft lip	6.12e-05	0.000105	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—FGFR1—cleft lip	6.01e-05	0.000103	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—MTR—cleft lip	5.91e-05	0.000101	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—TYMS—cleft lip	5.88e-05	0.000101	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—FGF2—cleft lip	5.84e-05	0.0001	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—FGF2—cleft lip	5.79e-05	9.93e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—NOS3—cleft lip	5.76e-05	9.88e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—FGF2—cleft lip	5.72e-05	9.8e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—NOS3—cleft lip	5.71e-05	9.79e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—FGFR3—cleft lip	5.68e-05	9.75e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—NOS3—cleft lip	5.64e-05	9.67e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—TYMS—cleft lip	5.54e-05	9.5e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—TYMS—cleft lip	5.49e-05	9.42e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—FGF2—cleft lip	5.41e-05	9.27e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—NOS3—cleft lip	5.33e-05	9.15e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—FGF2—cleft lip	5.32e-05	9.13e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—NOS3—cleft lip	5.25e-05	9e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—NOS3—cleft lip	5.18e-05	8.88e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—MTHFR—cleft lip	5.14e-05	8.81e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—MTHFR—cleft lip	4.84e-05	8.3e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—MTHFR—cleft lip	4.8e-05	8.23e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—NOS3—cleft lip	4.76e-05	8.16e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—FGF2—cleft lip	4.73e-05	8.11e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—TYMS—cleft lip	4.69e-05	8.05e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—NOS3—cleft lip	4.66e-05	7.99e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—NOS3—cleft lip	4.49e-05	7.69e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—FGF2—cleft lip	4.39e-05	7.53e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—NOS3—cleft lip	4.33e-05	7.43e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—MYC—cleft lip	4.19e-05	7.19e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—MTHFR—cleft lip	4.1e-05	7.03e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—MYC—cleft lip	3.82e-05	6.55e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—MYC—cleft lip	3.79e-05	6.49e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—MYC—cleft lip	3.74e-05	6.41e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—TYMS—cleft lip	3.62e-05	6.21e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—NOS3—cleft lip	3.58e-05	6.14e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MYC—cleft lip	3.54e-05	6.06e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MYC—cleft lip	3.48e-05	5.97e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—NOS3—cleft lip	3.38e-05	5.79e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—NOS3—cleft lip	3.35e-05	5.74e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—MTHFR—cleft lip	3.16e-05	5.43e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MYC—cleft lip	3.09e-05	5.3e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MYC—cleft lip	2.87e-05	4.92e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—NOS3—cleft lip	2.86e-05	4.9e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—NOS3—cleft lip	2.21e-05	3.78e-05	CbGpPWpGaD
